OCUGEN INC. - COMMON STOCK
1.3450
02-May-24 13:58:31
15 minutes delayed
Stocks
-0.0450
-3.24%
Today's range
1.3200 - 1.4100
ISIN
N/A
Source
NASDAQ
-
Ocugen Announces CSO to Present on Modifier Gene Therapy at Retina World Congress
02 May 2024 07:15:46 By Nasdaq GlobeNewswire
-
29 Apr 2024 06:45:00 By Nasdaq GlobeNewswire
-
26 Apr 2024 09:05:24 By Nasdaq GlobeNewswire
-
26 Apr 2024 06:30:40 By Nasdaq GlobeNewswire
-
19 Apr 2024 07:13:05 By Nasdaq GlobeNewswire
-
12 Apr 2024 07:30:34 By Nasdaq GlobeNewswire
-
Ocugen Provides Business Update with Certain Financials for the Year Ending 2023
02 Apr 2024 08:00:39 By Nasdaq GlobeNewswire
-
01 Apr 2024 17:43:45 By Nasdaq GlobeNewswire
-
Ocugen, Inc. Appoints Huma Qamar, MD, MPH as Chief Medical Officer
18 Mar 2024 06:30:50 By Nasdaq GlobeNewswire
-
13 Mar 2024 08:00:54 By Nasdaq GlobeNewswire
-
Ocugen to Present at Investing in Cures Summit
06 Mar 2024 07:30:09 By Nasdaq GlobeNewswire
-
Ocugen Clinical Showcase Webcast Now Available
28 Feb 2024 08:00:26 By Nasdaq GlobeNewswire
-
Ocugen Chairman and CEO to present at Abu Dhabi Family Office Summit
26 Feb 2024 08:30:13 By Nasdaq GlobeNewswire
-
22 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
-
Ocugen to Present at 2024 BIO CEO & Investor Conference
21 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
-
Ocugen to Host Clinical Showcase in New York City on Wednesday, February 21, 2024
14 Feb 2024 07:30:49 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >